Promaxo, a medical imaging, robotics, and AI technology company, announced closing an investment round of $4.17 million led by Huami Corp (NYSE: HMI). The funding will accelerate the company’s data strategy and continued integration of artificial intelligence in imaging and image-based interventions.
According to Dr. Amit Vohra, founder and CEO, the company is “introducing our truly open MRI system to the masses” and leveraging this support to execute their vision of providing advanced healthcare solutions.
The funds will be directed toward expanding Promaxo’s capabilities in medical imaging, robotics, and artificial intelligence with a patient-centric approach. Huami Chief Operating Officer Mike Yeung highlighted the strategic fit, noting that companies like Promaxo are “disrupting the locations, applications and costs of medical imaging.”
Both organizations plan to explore partnerships in artificial intelligence applications, product integration, and commercialization. Promaxo, based in Oakland, California, is backed by over 60 patents and focuses on developing minimally-invasive MRI and robotic platforms. Huami, founded in 2013, specializes in AI chips, biometric sensors, and health technology products.